Literature DB >> 8350057

A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens.

D A Rowley1, R M Stach.   

Abstract

A first or dominant immunization with one antigen markedly inhibited specific cytolytic T lymphocyte (CTL) responses to a second unrelated alloantigen without suppressing antibody responses to other antigens. Suppression was induced rapidly, became systemic, and could be transferred passively with only serum. Suppression did not result from elimination of cells capable of responding to the second antigen. The mechanisms responsible for this "priority of the first response" may be the same that help protect the fetus during pregnancy, promote renal allograft survival after multiple blood transfusions, and prevent effective CTL-mediated immunity to variants of tumor cells or infectious agents that arise during tumor progression or chronic infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350057      PMCID: PMC2191159          DOI: 10.1084/jem.178.3.835

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Powerful immunosuppression mediated by interleukin 2-activated, nonantigen-specific, or H-2-restricted THY-1+ CD8+ cells.

Authors:  G Torre-Amione; R Tuetken; D A Rowley
Journal:  Cell Immunol       Date:  1989-11       Impact factor: 4.868

2.  Improvement of kidney-graft survival with increased numbers of blood transfusions.

Authors:  G Opelz; P I Terasaki
Journal:  N Engl J Med       Date:  1978-10-12       Impact factor: 91.245

3.  Antigen competition: a paradox.

Authors:  R H Waterston
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

4.  Antigen competition: antigens compete for a cell occurring with limited frequency.

Authors:  J F Albright; T F Omer; J W Deitchman
Journal:  Science       Date:  1970-01-09       Impact factor: 47.728

5.  Prevention of recurrent abortion with leucocyte transfusions.

Authors:  C Taylor; W P Faulk
Journal:  Lancet       Date:  1981-07-11       Impact factor: 79.321

6.  Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells.

Authors:  G Möller; O Sjöberg
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

7.  Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans.

Authors:  A E Beer; J F Quebbeman; J W Ayers; R F Haines
Journal:  Am J Obstet Gynecol       Date:  1981-12-15       Impact factor: 8.661

8.  Antigenic competition between polypeptidyl determinants in normal and tolerant rabbits.

Authors:  I Schechter
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

9.  Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.

Authors:  J L Urban; R C Burton; J M Holland; M L Kripke; H Schreiber
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

10.  Suppression by autogenous complementary idiotypes: the priority of the first response.

Authors:  D A Rowley; H Köhler; H Schreiber; S T Kaye; I Lorbach
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  5 in total

1.  Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells.

Authors:  M Harada; K Tatsugami; M Nomoto; K Nomoto
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.

Authors:  Jay Friedman; Ellen C Moore; Paul Zolkind; Yvette Robbins; Paul E Clavijo; Lilian Sun; Sarah Greene; Megan V Morisada; Wojciech K Mydlarz; Nicole Schmitt; James W Hodge; Hans Schreiber; Carter Van Waes; Ravindra Uppaluri; Clint Allen
Journal:  Clin Cancer Res       Date:  2019-10-23       Impact factor: 12.531

3.  T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.

Authors:  S A Kalams; R P Johnson; M J Dynan; K E Hartman; T Harrer; E Harrer; A K Trocha; W A Blattner; S P Buchbinder; B D Walker
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

4.  Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses.

Authors:  D A Rowley; E T Becken; R M Stach
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

5.  A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens.

Authors:  R M Stach; D A Rowley
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.